Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient characteristics in the benign and malignant neurogenic tumor groups

From: Primary intrathoracic malignant neurogenic tumor: report of three cases and comparison with benign neurogenic tumors resected at our institution

  BNT ( n= 21) MNT ( n= 3)
Gender (male/female) 13/8 2/1
Age (years) 52 ± 18 (15 to 72)a 27 ± 14 (17 to 43)a
Symptom (yes/no) 2/19 1/2
Location PM: 16 PM: 3
  Middle: 1  
  CW: 4  
Tumor size 33.9 ± 22.8 (11 to 90)a 43 ± 6.1 (30 to 50)a
Intraspinal extension (yes/no) 19/2 2/1
FDG-PET (positive/negative/not examined) 5/2/14 0/0/3
Surgical approach VATS: 18 VATS: 1
  VATS + Post: 2 VATS → Open: 1
  Open: 1 VATS + Post: 1
Prognosis Alive without Rec: 21 Died of tumor: 3
  1. BNT, benign neurogenic tumor; MNT, malignant neurogenic tumor; PM, posterior mediastinal; Middle, middle mediastinal; CW, chest wall; VATS, video-assisted thoracic surgery; Post, posterior approach; Open, thoracotomy; Rec: recurrence. aMean ± standard deviation (range).